Literature DB >> 19640896

Increased hypoxia and reduced renal tubular response to furosemide detected by BOLD magnetic resonance imaging in swine renovascular hypertension.

Sabas I Gomez1, Lizette Warner, John A Haas, Rodney J Bolterman, Stephen C Textor, Lilach O Lerman, Juan Carlos Romero.   

Abstract

Oxygen consumption beyond the proximal tubule is mainly determined by active solute reabsorption, especially in the thick ascending limb of the Loop of Henle. Furosemide-induced suppression of oxygen consumption (FSOC) involves inhibition of sodium transport in this segment, which is normally accompanied by a marked decrease in the intrarenal deoxyhemoglobin detectable by blood oxygen level-dependent (BOLD)-magnetic resonance imaging (MRI). This study tested the hypothesis that the magnitude of BOLD-MRI signal change after furosemide is related to impaired renal function in renovascular hypertension. In 16 pigs with unilateral renal artery stenosis, renal hemodynamics, function, and tubular function (FSOC and fluid concentration capacity) were evaluated in both kidneys using MR and multidetector computerized tomography (MDCT) imaging. Animals with adequate FSOC (23.6 +/- 2.2%, P > 0.05 vs. baseline) exhibited a mean arterial pressure (MAP) of 113 +/- 7 mmHg, and relatively preserved glomerular filtration rate (GFR) of 60 +/- 4.5 ml/min, comparable to their contralateral kidney (66 +/- 4 ml/min, P > 0.05). In contrast, animals with low FSOC (3.1 +/- 2.1%, P = NS vs. baseline) had MAP of 124 +/- 9 mmHg and GFR (22 +/- 6 ml/min) significantly lower than the contralateral kidneys (66 +/- 4 ml/min, P < 0.05). The group with preserved GFR and FSOC showed an increase in intratubular fluid concentration as assessed by MDCT that was greater than that observed in the low GFR group, suggesting better preservation of tubular function in the former group. These results suggest that changes in BOLD-MRI after furosemide can differentiate between underperfused kidneys with preserved tubular function and those with tubular dysfunction. This approach may allow more detailed physiologic evaluation of poststenotic kidneys in renovascular hypertension than previously possible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19640896      PMCID: PMC2775582          DOI: 10.1152/ajprenal.90757.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  42 in total

1.  Combination of hypercholesterolemia and hypertension augments renal function abnormalities.

Authors:  M Rodriguez-Porcel; J D Krier; A Lerman; P F Sheedy; J C Romero; C Napoli; L O Lerman
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

2.  Noninvasive measurement of concurrent single-kidney perfusion, glomerular filtration, and tubular function.

Authors:  J D Krier; E L Ritman; Z Bajzer; J C Romero; A Lerman; L O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2001-10

3.  Effects of furosemide on medullary oxygenation in younger and older subjects.

Authors:  F H Epstein; P Prasad
Journal:  Kidney Int       Date:  2000-05       Impact factor: 10.612

4.  Noninvasive evaluation of a novel swine model of renal artery stenosis.

Authors:  L O Lerman; R S Schwartz; J P Grande; P F Sheedy; J C Romero
Journal:  J Am Soc Nephrol       Date:  1999-07       Impact factor: 10.121

5.  Effects of the intravenously administered anaesthetics ketamine, propofol, and thiamylal on the cortical renal blood flow in rats.

Authors:  Yousuke Shiga; Kouichiro Minami; Yasuhito Uezono; Kayoko Segawa; Etsuko Nagaoka; Munehiro Shiraishi; Takashi Noguchi; Akio Shigematsu
Journal:  Pharmacology       Date:  2003-05       Impact factor: 2.547

6.  Effect of diabetes on renal medullary oxygenation during water diuresis.

Authors:  Franklin H Epstein; Aristidis Veves; Pottumarthi V Prasad
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

7.  Evaluation of the reproducibility of intrarenal R2* and DeltaR2* measurements following administration of furosemide and during waterload.

Authors:  Lu-Ping Li; Pippa Storey; Linda Pierchala; Wei Li; Jason Polzin; Pottumarthi Prasad
Journal:  J Magn Reson Imaging       Date:  2004-05       Impact factor: 4.813

8.  Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joseph P Grande; Xiangyang Zhu; Vincenzo Sica; Claudio Napoli; Tatsuya Sawamura; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-05-15       Impact factor: 8.311

9.  Blood oxygen level-dependent measurement of acute intra-renal ischemia.

Authors:  Laurent Juillard; Lilach O Lerman; David G Kruger; John A Haas; Brian C Rucker; Jason A Polzin; Stephen J Riederer; Juan C Romero
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

10.  Distinct renal injury in early atherosclerosis and renovascular disease.

Authors:  Alejandro R Chade; Martin Rodriguez-Porcel; Joseph P Grande; James D Krier; Amir Lerman; J Carlos Romero; Claudio Napoli; Lilach O Lerman
Journal:  Circulation       Date:  2002-08-27       Impact factor: 29.690

View more
  26 in total

Review 1.  Renal oxidative stress, oxygenation, and hypertension.

Authors:  Fredrik Palm; Lina Nordquist
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 2.  Atherosclerotic renal artery stenosis: current status.

Authors:  Soon Hyo Kwon; Lilach O Lerman
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

3.  Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis.

Authors:  Monika L Gloviczki; James F Glockner; Lilach O Lerman; Michael A McKusick; Sanjay Misra; Joseph P Grande; Stephen C Textor
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

Review 4.  Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension.

Authors:  Monika L Gloviczki; Lilach O Lerman; Stephen C Textor
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

5.  Intra-renal oxygenation in rat kidneys during water loading: effects of cyclooxygenase (COX) inhibition and nitric oxide (NO) donation.

Authors:  Lin Ji; Lu-Ping Li; Thomas Schnitzer; Hongyan Du; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

6.  Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.

Authors:  Alejandro R Chade; Maxx L Williams; Erika Guise; Luke J Vincent; Taylor W Harvey; Marija Kuna; Fakhri Mahdi; Gene L Bidwell
Journal:  Kidney Int       Date:  2017-12-19       Impact factor: 10.612

7.  Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease.

Authors:  Monika L Gloviczki; James F Glockner; John A Crane; Michael A McKusick; Sanjay Misra; Joseph P Grande; Lilach O Lerman; Stephen C Textor
Journal:  Hypertension       Date:  2011-10-31       Impact factor: 10.190

8.  Renal blood oxygenation level-dependent imaging: contribution of R2 to R2* values.

Authors:  Pierre-Hugues Vivier; Pippa Storey; Hersh Chandarana; Akira Yamamoto; Kristopher Tantillo; Umer Khan; Jeff L Zhang; Eric E Sigmund; Henry Rusinek; James S Babb; Michael Bubenheim; Vivian S Lee
Journal:  Invest Radiol       Date:  2013-07       Impact factor: 6.016

9.  Changes in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosis.

Authors:  Alfonso Eirin; Behzad Ebrahimi; Xin Zhang; Xiang-Yang Zhu; Hui Tang; John A Crane; Amir Lerman; Stephen C Textor; Lilach O Lerman
Journal:  Circ Cardiovasc Interv       Date:  2012-10-09       Impact factor: 6.546

10.  Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism.

Authors:  Taylor W Harvey; Jason E Engel; Alejandro R Chade
Journal:  Am J Nephrol       Date:  2016-03-02       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.